Search
Evaxion Biotech A/S
EVAXAdd to Watchlist
2.830USD
+0.030+1.07%
Close 10-16 16:00（ET）
25.53MMarket Cap
LossP/E TTM
Evaxion Biotech A/S (EVAX) Stock Price Target & Forecast
Analyst Rating
Based on 4 analysts giving stock ratings to Evaxion Biotech A/S in the past month.
Buy
0 Strong Buy
4 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
11.250USD+307.61%
EVAX Analyst Recommendation Trends
In the current month, EVAX has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. EVAX average Analyst price target in the last month is 11.250.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
4
4
4
4
4
4
4
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
4
4
4
4
4
4
EVAX Analyst Rating for Peer Comparison
Updated: Oct 15, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Insmed Inc
INSM
7
18
0
0
0
25
Kymera Therapeutics Inc
KYMR
9
13
2
0
0
24
Revolution Medicines Inc
RVMD
9
14
1
0
0
24
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
12
7
0
0
23
IQVIA Holdings Inc
IQV
8
12
3
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Financial Forecasting
Based on analysts' estimates, EVAX EPS is projected to reach -0.293 in FY2026Q3, following reported EPS of -0.447 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.30
-0.30
-0.31
-0.29
-0.27
Actual
-0.72
-0.43
-0.45
--
--
Surprise
-142.02%
-43.41%
-42.66%
--
--
FAQs
What is Evaxion Biotech A/S's price target?
Analysts forecast that Evaxion Biotech A/S's price target is USD 11.25, with the highest forecast at USD 16.00 and the lowest forecast at USD 9.00.
How have Evaxion Biotech A/SEVAX's recent earnings per share performed?
The market expectation was USD -0.45, while Evaxion Biotech A/SEVAX's earnings per share (EPS) for the previous quarter was USD -0.43. EPS for the next quarter is expected at USD -0.29.
What is the analyst rating for Evaxion Biotech A/S?
Based on the ratings of Evaxion Biotech A/S's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.